Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

AIDS patients not taking their medications, new study shows

May 7, 1998

Trimeris reports anti-HIV drug with a novel mechanism of action

May 7, 1998

New AIDS immunotherapeutic in development by Australian company

May 5, 1998

Enzo Biochem receives SBIR grant to support development of AIDS drug

May 5, 1998

Two-vaccine combination for HIV shows promise in clinical trial

May 5, 1998

Gilead prepares orally active prodrugs of PMPA

April 30, 1998

Fasudil hydrochloride inhibits HIV-1 replication in vitro

April 28, 1998

Oxandrin approved in South Korea and the Azerbaijan Republic

April 27, 1998

Novopharm seeks FDA approval to begin phase Ib/II trials with GPI-2A

April 24, 1998

PRO-542 demonstrates potent antiviral activity

April 24, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.